Efficacy of a therapy with "polivalent mechanical bacterial lysate" on a prison population caracterized by high risk bacterial respiratory infections;Efficacia di una terapia condotta con "lisato meccanico batterico polivalente" su di una popolazione carceraria ad alto rischio di infezioni batteriche respiratorie

GIMT - Giornale Italiano delle Malattie del Torace

Volumn 58, Issue 1, 2004, Pages 27-33

  Boris, V M ^a   Sybirna, R ^b   Gunin, O Mihajlovic ^b  

^a Accademia delle Scienze di Ucraina   (Ukraine)

^b L'Viv Institute of Internal Affair

Author keywords

Bacterial respiratory infections; Polivalent mechanical bacterical lysat; Prison population

Indexed keywords

BACTERIAL VACCINE; BACTERIUM LYSATE; POLYVALENT MECHANICAL BACTERIUM LYSATE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CUSTODY; DIET; DISEASE SEVERITY; DRUG EFFICACY; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PHYSICAL STRESS; PRISON; PUBLIC HEALTH SERVICE; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; VACCINATION;

EID: 4944258494     PISSN: 11270810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baillargeon J, Black SA, Pulvino J, Dunn K. The disease profile of Texas prison inmaites. Ann Epidemiol 2000; 10: 74-80.
2. Castle White M. Identifying infectious disease in prisons: surveillance, protection and intervention. West J Med 1999; 170: 177.
3. Valway SE, Richards SB, Kovacovich J, Greifinger RB, Crawford JT, Dooley SW. Outbreak of multi-drug-resistant tuberculosis in New York State prison, 1991. Am J Epidemiol. 1994; 140: 113-22.
4. Sanches VM, Alvares-Guisasola F, A Cayla J, Alvarez J. Predictive factors of Mycobacterium tuberculosis infection and pulmonary tuberculosis in prisoners. Int J Epidemiol 1995; 24: 630-6.
5. Mac Intyre CR, Kendig K, Kummer L, Birago S et al. Unrecognised trasmission of tuberculosis in prison. Eur J Epidemiol 1999; 15: 705-9.
6. McIntyre CR, Carnie J, Randal M. Risk of trasmission of tuberculosis among inmaites of an Australian prison. Epidemiol Infect 1999; 123: 445-50.
7. Behrendt C, Kendig N, Dambita C, Horman J et al. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol 1994; 139: 918-26.
8. Muller R, Stark K, Guggenmoos Holzmann I et al. Inprisonment: a risk factor for HIV infection counteracting education and prevention programmes for intravenous drug user. AIDS 1995; 9: 183-90.
9. Martin V, Cayla JM, Morìs ML et al. Predictive factors of HIV-infection in injecting drug users upon incarceration. Eur J Epidemiol 1998; 14: 327-31.
10. Taylor A, Goldberg D, Emslie J, Wrench J et al. Outbreack of HIV infection in a Scottish prison. BMJ 1995; 310: 289-92.
11. National Commission On Correctional Health Care. The heath status of soon-to-be released inmates. Chicago (IL), 2002.
12. Le Monde diplomatique. Giugno 2003.
13. Marini V, Dalla Torre L, Bertoncello C. La popolazione carceraria: aspetti normativi ed epidemiologici, analisi della letteratura. Igiene e Sanità Pubblica. 2002; LVIII (6): 441-55.
14. Cogo R, Ramponi A, Scivoletto G, Rippoli R. Profilassi degli episodi di riacutizzazione in corso di brochite cronica ostruttiva con un vaccino antibatterico sublinguale ottenuto per lisi meccanica: uno studio clinico e farmacologico. Acta Biomedica 2003; 74: 81-7.
15. Rossi GA, Peri C, Raynal ME, Defilippi AC, Risso FM, Schenone G, Pallestrini E, Melioli G. Naturally occurring immune response aginst bacteria commonly involved in upper respiratory tract infections: analysis of the antigen specific salivary IgA levels; Immunology Letters 2003; 86: 85-91.
16. Blasi F. Vaccinoprofilassi delle infezioni respiratorie: efficacia di un lisato batterico per via meccanica. Giorn It Mal Tor 2002; 56: 85-99.
17. Melioli G. Opsonizzazione: mangiare o essere mangiato. Giorn It Mal Tor 2002; 56: 245-8.
18. Rossi S, Tazza R. Valutazione dell'efficacia e della tollerabilità di un nuovo vaccino immunostimolante (Ismigen®), ottenuto per lisi meccanica, nella prevenzione delle patologie infettive delle basse vie respiratorie. American College of Chest Physicians, Italian Chapter 2002.
19. Boris VM. Profilassi degli episodi di infezione delle vie aeree durante la stagione invernale con un vaccino antibatterico sublinguale ottenuto per lisi meccanica: studio clinico su pazienti affetti da prregresa malattia tubercolare. Giorn It Mal Tor 2003; 57: 210-5.
20. Collet JP, Ducruet T, Haider S, Shapiro S, Robinson A, Renzi PM, Contandriopoulos AP, Ernst P. Economic impact of using immunostimulating agent to prevent severe acute exacerbations in patients with chronic obstructive pulmonary disease. Can Respir J 2001; 8: 27-33.
21. National Center for Health Statistics. Current estimates from the National Health Inteview Survey, United States, 1981. Vital and Health Statistic series, 10 (141). Washington: US Government Printing Office, 1982.
22. Workshop report "Global Initiative for the Diagnosis, Management and Prevention of chronic Obstuctive Lung Disease (GOLD)" - NHLBI, OMS. Am J Respir Crit Care Med 2001; 163: 1256-75.
23. Marini V, Dalla Torre L, Bertoncello C. La popolazione carcararia: aspetti normativi ed epidemiologici, analisi della letteratura. Igiene e Sanità Pubblica 2002; vol LVIII: 6, 441-5.
24. National Commission on correctional health care. The heath status of soon-to-be released inmates, Chicago (IL), 2002.